Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients
Litao Xu(Shanghai Medical College of Fudan University), Zhiqiang Meng(Fudan University Shanghai Cancer Center)
Cited by 93
Related Papers
The serum miR‐21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR‐21 expression confers chemoresistance by targeting FasL
|Molecular Oncology|2012|184
FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1
|Cell Communication and Signaling|2020|93
Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression
|Journal of Experimental & Clinical Cancer Research|2019|86
Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling
|International Journal of Oncology|2018|46
Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signaling
|International Journal of Oncology|2016|42